Visser PJ - Search Results

1

Tau and p-tau as CSF biomarkers in dementia: a meta-analysis.

van Harten AC, Kester MI, Visser PJ, Blankenstein MA, Pijnenburg YA, van der Flier WM, Scheltens P. van Harten AC, et al. Among authors: visser pj. Clin Chem Lab Med. 2011 Mar;49(3):353-66. doi: 10.1515/CCLM.2011.086. Epub 2011 Feb 23. Clin Chem Lab Med. 2011. PMID: 21342021 Review.

2

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.

Visser PJ, Scheltens P, Verhey FR, Schmand B, Launer LJ, Jolles J, Jonker C. Visser PJ, et al. J Neurol. 1999 Jun;246(6):477-85. doi: 10.1007/s004150050387. J Neurol. 1999. PMID: 10431775

3

Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.

Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Visser PJ, et al. J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):491-7. doi: 10.1136/jnnp.72.4.491. J Neurol Neurosurg Psychiatry. 2002. PMID: 11909909 Free PMC article.

4

Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects.

Visser PJ, Verhey FR, Scheltens P, Cruts M, Ponds RW, Van Broeckhoven CL, Jolles J. Visser PJ, et al. J Neurol. 2002 Mar;249(3):312-9. doi: 10.1007/s004150200011. J Neurol. 2002. PMID: 11993532 Clinical Trial.

5

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

Korf ES, Wahlund LO, Visser PJ, Scheltens P. Korf ES, et al. Among authors: visser pj. Neurology. 2004 Jul 13;63(1):94-100. doi: 10.1212/01.wnl.0000133114.92694.93. Neurology. 2004. PMID: 15249617

6

Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease.

Karas GB, Scheltens P, Rombouts SA, Visser PJ, van Schijndel RA, Fox NC, Barkhof F. Karas GB, et al. Among authors: visser pj. Neuroimage. 2004 Oct;23(2):708-16. doi: 10.1016/j.neuroimage.2004.07.006. Neuroimage. 2004. PMID: 15488420 Clinical Trial.

7

Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients.

Visser PJ, Scheltens P, Pelgrim E, Verhey FR; Dutch ENA-NL-01 Study Group. Visser PJ, et al. Dement Geriatr Cogn Disord. 2005;19(2-3):126-33. doi: 10.1159/000082883. Epub 2004 Dec 23. Dement Geriatr Cogn Disord. 2005. PMID: 15627759

8

Biomarker profiles and their relation to clinical variables in mild cognitive impairment.

Schoonenboom SN, Visser PJ, Mulder C, Lindeboom J, Van Elk EJ, Van Kamp GJ, Scheltens PH. Schoonenboom SN, et al. Among authors: visser pj. Neurocase. 2005 Feb;11(1):8-13. doi: 10.1080/13554790490896785. Neurocase. 2005. PMID: 15804919

9

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

Visser PJ, Scheltens P, Verhey FR. Visser PJ, et al. J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1348-54. doi: 10.1136/jnnp.2004.047720. J Neurol Neurosurg Psychiatry. 2005. PMID: 16170074 Free PMC article. Clinical Trial.

10

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Dubois B, et al. Among authors: visser pj. Lancet Neurol. 2007 Aug;6(8):734-46. doi: 10.1016/S1474-4422(07)70178-3. Lancet Neurol. 2007. PMID: 17616482 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

383 results

Search Page

Filters